> All the big AIM fraud exposés
> 300 articles and podcasts a month
> Hot share tips
> Original investigations by our experienced team
> No ads, no click-bait, no auto-play videos
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
Updating earlier this month on Obtala Resources (OBT) with the shares then at 6.375p, we noted the valuation looked to fail to reflect the asset backing and likely news flow but a disappointing share price performance from a now long-running recommendation. It is now boardroom change ahoy.
This is with Frank Scolaro retiring from the Chairman's role (though remaining on the board as a non-executive) and Emma Priestley - who we always thought was dead wood - departing from the board, with Miles Pelham becoming Chairman.
Pelham joined Obtala as a non-executive director in August, with experience in senior investment banking positions within multinational financial institutions and with Scolaro now adding that he has already enriched the company via his network of investors and business contacts within Asia and beyond.
Pelham will work with Managing Director Simon Rollason and states “I can assure shareholders that I will maintain a simple business model of monetizing our assets and sunk investment whilst keeping clinical control of costs amidst strong corporate governance. I look forward to updating shareholders in the imminent future of our medium-term plans and meeting many of them in person at the UK Investor Show being held at the QEII Conference centre in London on the Saturday 30th of April".
This is a reassuring approach and the noting also that “the company sits at the cusp of healthy revenue expansion from its considerable asset base”chimes with our rationale for maintaining faith here.
The shares have responded 16% higher to 7.25p on the back of the news, but this is hopefully just the start of fresh positive momentum here. Our stance remains buy – and, as Pelham reminds, to further understand why the company can be seen at UK Investor Show this coming Saturday. Tom W is also planning a private meet with Pelham and will report back afterwards.
Never miss a story.
This area of the ShareProphets.com site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of ShareProphets.com. ShareProphets.com does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at ShareProphets.com is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by ShareProphets.com and is not intended to be relied upon by users in making (or refraining from making) any investment decisions.
Search ShareProphets |
Stock market news |
Recent Comments |
Site by Everywhen